Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / American Depositary Shares, each representing 1 Ordinary Shares
-
Shares outstanding
-
100M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
15.4M
-
Shares change
-
-858K
-
Total reported value, excl. options
-
$194M
-
Value change
-
-$11.5M
-
Put/Call ratio
-
0.86
-
Number of buys
-
28
-
Number of sells
-
-32
-
Price
-
$12.61
Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q3 2021
83 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q3 2021.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.4M shares
of 100M outstanding shares and own 15.33% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (3.78M shares), Capital International Investors (1.34M shares), PRINCIPAL FINANCIAL GROUP INC (1.24M shares), CREDIT SUISSE AG/ (1.2M shares), BAILLIE GIFFORD & CO (1.08M shares), Capital World Investors (875K shares), CAPITAL INTERNATIONAL INC /CA/ (863K shares), Sumitomo Mitsui Trust Holdings, Inc. (696K shares), Nikko Asset Management Americas, Inc. (696K shares), and Bpifrance SA (426K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.